{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:26:35Z","timestamp":1793042795066,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T00:00:00Z","timestamp":1726358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ejogrb.2024.09.019","type":"journal-article","created":{"date-parts":[[2024,10,2]],"date-time":"2024-10-02T00:03:50Z","timestamp":1727827430000},"page":"332-338","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Alternatives to surveillance for persistent human papillomavirus after a positive cervical screen: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"302","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8074-3538","authenticated-orcid":false,"given":"A.E.","family":"McGee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Hawco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bhattacharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.J.B.","family":"Hanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.E.","family":"Cruickshank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejogrb.2024.09.019_b0005","unstructured":"International Agency for Research on Cancer. World Health Organisation. Statistics at a glance, 2022 Top 5 most frequent cancers [Internet]. Available from: https:\/\/gco.iarc.who.int\/media\/globocan\/factsheets\/populations\/900-world-fact-sheet.pdf."},{"issue":"1","key":"10.1016\/j.ejogrb.2024.09.019_b0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2303.2008.00567.x","article-title":"Prediction of recurrent disease by cytology and HPV testing after treatment of cervical intraepithelial neoplasia","volume":"20","author":"Aerssens","year":"2009","journal-title":"Cytopathology"},{"key":"10.1016\/j.ejogrb.2024.09.019_b0015","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bpobgyn.2017.08.015","article-title":"The natural history of human papillomavirus infection","volume":"47","author":"de Sanjos\u00e9","year":"2018","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.ejogrb.2024.09.019_b0020","article-title":"Human papillomavirus persistence or clearance after infection in reproductive age. What is the status? Review of the literature and new data of a vaginal gel containing silicate dioxide, citric acid, and selenite","volume":"17","author":"Huber","year":"2021","journal-title":"Womens Health (Lond)"},{"key":"10.1016\/j.ejogrb.2024.09.019_b0025","unstructured":"World Health Organization. WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition. Geneva: 2021. Licence: CC BY-NC-SA 3.0 IGO."},{"issue":"5 Suppl 1","key":"10.1016\/j.ejogrb.2024.09.019_b0030","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/LGT.0b013e318287d329","article-title":"2012 ASCCP Consensus Guidelines Conference, et al. 2012 Updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors","volume":"17","author":"Massad","year":"2013","journal-title":"J Low Genit Tract Dis"},{"key":"10.1016\/j.ejogrb.2024.09.019_b0035","first-page":"1","article-title":"Influence of human papillomavirus infection on the natural history of cervical intraepithelial neopla- sia 1: a meta-analysis","volume":"2017","author":"Liu","year":"2017","journal-title":"Biomed Res Int"},{"issue":"2","key":"10.1016\/j.ejogrb.2024.09.019_b0040","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/sti.2005.016436","article-title":"Social and psychological impact of HPV testing in cervical screening: a qualitative study","volume":"82","author":"McCaffery","year":"2006","journal-title":"Sex Transm Infect"},{"key":"10.1016\/j.ejogrb.2024.09.019_b0045","unstructured":"Public Health England. Cervical screening: programme overview [Internet]. GOV.YK> 2021. Available from: https:\/\/www.gov.uk\/guidance\/cervical-screening-programme-overview. Date accessed: 03\/03\/2024."},{"key":"10.1016\/j.ejogrb.2024.09.019_b0050","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"366","key":"10.1016\/j.ejogrb.2024.09.019_b0055","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"28","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.ejogrb.2024.09.019_b0060","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.ejogrb.2024.09.019_b0065","doi-asserted-by":"crossref","DOI":"10.31557\/APJCP.2022.23.4.1285","article-title":"Efficacy of oral zinc sulfate supplementation on clearance of cervical human papillomavirus (HPV); A randomized controlled clinical trial","author":"Ayatollahi","year":"2022","journal-title":"Asian Pacific J Cancer Prevent."},{"issue":"5","key":"10.1016\/j.ejogrb.2024.09.019_b0070","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3390\/medicina58050646","article-title":"Echinacea angustifolia and Echinacea purpureaSupplementation combined with vaginal hyaluronic acid to boost the remission of cervical low-grade squamous intraepithelial lesions (L-SILs): A randomized controlled trial","volume":"58","author":"Riemma","year":"2022","journal-title":"Medicina (Kaunas)"},{"issue":"9","key":"10.1016\/j.ejogrb.2024.09.019_b0075","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1093\/cid\/ciab369","article-title":"Local hyperthermia at 44\u00b0C is effective in clearing cervical high-risk human papillomaviruses: a proof-of-concept, randomized controlled clinical trial","volume":"73","author":"Yang","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.ejogrb.2024.09.019_b0080","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1002\/ijc.32344","article-title":"REBACIN\u00ae as a noninvasive clinical intervention for high-risk human papillomavirus persistent infection","volume":"145","author":"Yang","year":"2019","journal-title":"Int J Cancer"},{"issue":"6","key":"10.1016\/j.ejogrb.2024.09.019_b0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0217745","article-title":"Short-term clinical and immunologic effects of poly-gamma-glutamic acid (\u03b3-PGA) in women with cervical intraepithelial neoplasia 1 (CIN 1): A multicenter, randomized, double blind, phase II trial","volume":"14","author":"Cho","year":"2019","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ejogrb.2024.09.019_b0090","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ygyno.2013.12.034","article-title":"Results of a phase II randomized, double-blind, placebo-controlled trial of Polyphenon E in women with persistent high-risk HPV infection and low-grade cervical intraepithelial neoplasia","volume":"132","author":"Garcia","year":"2014","journal-title":"Gynecol Oncol"},{"issue":"12","key":"10.1016\/j.ejogrb.2024.09.019_b0095","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s00432-009-0617-1","article-title":"Elimination of high-risk human papillomavirus type HPV16 infection by 'Praneem' polyherbal tablet in women with early cervical intraepithelial lesions","volume":"135","author":"Shukla","year":"2009","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejogrb.2024.09.019_b0100","first-page":"99","article-title":"CO2-laser vaporization of human papillomavirus (HPV)-induced abnormal cervical smears. A simple and effective solution to a recurrent clinical problem","volume":"18","author":"Ruge","year":"1991","journal-title":"Clin Exp Obstet Gynecol."},{"issue":"15","key":"10.1016\/j.ejogrb.2024.09.019_b0105","first-page":"5509","article-title":"A retrospective study on two cohorts of immunocompetent women treated with nonavalent HPV vaccine vs. Ellagic acid complex: outcome of the evolution of persistent cervical HPV infection","volume":"26","author":"Moscato","year":"2022","journal-title":"Eur Rev Med Pharmacol Sci."},{"issue":"1","key":"10.1016\/j.ejogrb.2024.09.019_b0110","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1080\/02656736.2022.2130443","article-title":"Focused ultrasound for high-risk human papillomavirus infection-related low-grade cervical lesions: a prospective cohort study","volume":"39","author":"Wang","year":"2022","journal-title":"Int J Hyperthermia"},{"key":"10.1016\/j.ejogrb.2024.09.019_b0115","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.pdpdt.2015.12.004","article-title":"Topical photodynamic therapy with 5-aminolevulinic acid for cervical high-risk HPV infection","volume":"13","author":"Fu","year":"2016","journal-title":"Photodiagnosis Photodyn Ther"},{"issue":"2","key":"10.1016\/j.ejogrb.2024.09.019_b0120","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ygyno.2011.04.026","article-title":"A pilot study to investigate the treatment of cervical human papillomavirus infection with zinc-citrate compound (CIZAR\u00ae)","volume":"122","author":"Kim","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejogrb.2024.09.019_b0125","first-page":"1","article-title":"Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments","author":"McGuinness","year":"2020","journal-title":"Res Syn Meth."},{"issue":"3B","key":"10.1016\/j.ejogrb.2024.09.019_b0130","first-page":"1763","article-title":"Natural history of established low grade cervical intraepithelial (CIN 1) lesions","volume":"28","author":"Bansal","year":"2008","journal-title":"Anticancer Res"},{"issue":"6","key":"10.1016\/j.ejogrb.2024.09.019_b0135","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/ijc.10888","article-title":"A randomised, double-blind, pla- cebo-controlled trial of photodynamic therapy using 5-aminolaevulinic acid for the treatment of cervical intraepithelial neoplasia","volume":"103","author":"Barnett","year":"2003","journal-title":"Int J Cancer."},{"issue":"13","key":"10.1016\/j.ejogrb.2024.09.019_b0140","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1158\/1078-0432.CCR-04-2599","article-title":"Spontaneous regression of high- grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype","volume":"11","author":"Trimble","year":"2005","journal-title":"Clin Cancer Res."},{"key":"10.1016\/j.ejogrb.2024.09.019_b0145","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1086\/341782","article-title":"Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study","volume":"186","author":"Giuliano","year":"2002","journal-title":"J Infect Dis"},{"issue":"2021","key":"10.1016\/j.ejogrb.2024.09.019_b0150","first-page":"6627531","article-title":"Progression of CIN1\/LSIL HPV persistent of the cervix: actual progression or CIN3 coexistence","volume":"9","author":"Bruno","year":"2021","journal-title":"Infect Dis Obstet Gynecol"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030121152400513X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030121152400513X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T09:33:09Z","timestamp":1742031189000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030121152400513X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":30,"alternative-id":["S030121152400513X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2024.09.019","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alternatives to surveillance for persistent human papillomavirus after a positive cervical screen: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2024.09.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}